BR0315628A - Geração de ozÈnio mediada por anticorpo ou neutrófilo - Google Patents

Geração de ozÈnio mediada por anticorpo ou neutrófilo

Info

Publication number
BR0315628A
BR0315628A BR0315628-1A BR0315628A BR0315628A BR 0315628 A BR0315628 A BR 0315628A BR 0315628 A BR0315628 A BR 0315628A BR 0315628 A BR0315628 A BR 0315628A
Authority
BR
Brazil
Prior art keywords
antibody
ozone generation
neutrophil mediated
mediated
neutrophil
Prior art date
Application number
BR0315628-1A
Other languages
English (en)
Portuguese (pt)
Inventor
Paul Wentworth
Richard A Lerner
Original Assignee
Novartis Ag
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Scripps Research Inst filed Critical Novartis Ag
Publication of BR0315628A publication Critical patent/BR0315628A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
BR0315628-1A 2002-11-14 2003-11-13 Geração de ozÈnio mediada por anticorpo ou neutrófilo BR0315628A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42624502P 2002-11-14 2002-11-14
PCT/EP2003/012710 WO2004044582A2 (en) 2002-11-14 2003-11-13 Antibody- or neutrophil-mediated ozone generation

Publications (1)

Publication Number Publication Date
BR0315628A true BR0315628A (pt) 2005-08-23

Family

ID=32313124

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0315628-1A BR0315628A (pt) 2002-11-14 2003-11-13 Geração de ozÈnio mediada por anticorpo ou neutrófilo

Country Status (8)

Country Link
US (1) US20060292076A1 (enExample)
EP (1) EP1563299A2 (enExample)
JP (1) JP2006506613A (enExample)
CN (1) CN100570365C (enExample)
AU (1) AU2003288058A1 (enExample)
BR (1) BR0315628A (enExample)
CA (1) CA2505923A1 (enExample)
WO (1) WO2004044582A2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4998230B2 (ja) * 2007-11-26 2012-08-15 株式会社島津製作所 タンパク質試料中のメチオニン残基の酸化状態を解析する方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684521A (en) * 1982-12-08 1987-08-04 Frederic A. Bourke, Jr. Method and system for externally treating the blood
US4559157A (en) * 1983-04-21 1985-12-17 Creative Products Resource Associates, Ltd. Cosmetic applicator useful for skin moisturizing
LU84979A1 (fr) * 1983-08-30 1985-04-24 Oreal Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
US5162217A (en) * 1984-08-27 1992-11-10 Bio-Technology General Corp. Plasmids for expression of human superoxide dismutase (SOD) analogs containing lambda PL promoter with engineered restriction site for substituting ribosomal binding sites and methods of use thereof
US6030611A (en) * 1984-08-27 2000-02-29 Bio-Technology General Corp. Therapeutic SOD compositions and uses thereof
US5248603A (en) * 1985-09-03 1993-09-28 Symbicom Aktiebolag Superoxide dismutase
DE3619436A1 (de) * 1986-06-10 1987-12-17 Bayer Ag Triaryl- und trihetarylmethanderivate als redoxindikatoren und deren verwendung
US4820508A (en) * 1987-06-23 1989-04-11 Neutrogena Corporation Skin protective composition
US4992478A (en) * 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
DE4038563A1 (de) * 1990-12-04 1992-06-11 Gruenenthal Gmbh Verwendung von superoxiddismutasen zur prophylaxe und/oder behandlung von organversagen bei risikopatienten mit polytrauma
US5807884A (en) * 1992-10-30 1998-09-15 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
US5637315A (en) * 1993-01-04 1997-06-10 Thomas Jefferson University Treatment of disease states induced by oxidative stress
US5747026A (en) * 1993-10-15 1998-05-05 University Of Alabama At Birmingham Research Foundation Antioxidants
US5599712A (en) * 1993-10-15 1997-02-04 University Of Pittsburgh Protection from ionizing irradiation or chemotherapeutic drug damage by in vivo gene therapy
US5647315A (en) * 1994-10-07 1997-07-15 Yamaha Hatsudoki Kabushiki Kaisha Lubricating arrangement for engine
JPH08249306A (ja) * 1995-03-09 1996-09-27 Sharp Corp データ駆動型情報処理装置
US6822070B2 (en) * 1996-03-11 2004-11-23 David Baltimore Truncated CRAF1 inhibits CD40 signaling
AU2394597A (en) * 1996-04-18 1997-11-07 Medical Research Council Oxidative metabolism in smooth muscle cells: methods and materials relating thereto
GB9621440D0 (en) * 1996-10-15 1996-12-04 Renold Plc A chain tensioner
GB9622159D0 (en) * 1996-10-24 1996-12-18 Solvay Sociutu Anonyme Polyanionic polymers as adjuvants for mucosal immunization
US6040611A (en) * 1998-09-10 2000-03-21 Hughes Electonics Corporation Microelectromechanical device
EP1153010A1 (en) * 1999-02-08 2001-11-14 Checkpoint Genetics, Inc. $i(N)-SUBSTITUTED AMINO ACIDS, ANTIOXIDANT PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND METHODS USING SAME

Also Published As

Publication number Publication date
CN100570365C (zh) 2009-12-16
EP1563299A2 (en) 2005-08-17
WO2004044582A2 (en) 2004-05-27
AU2003288058A1 (en) 2004-06-03
JP2006506613A (ja) 2006-02-23
WO2004044582A3 (en) 2004-09-16
US20060292076A1 (en) 2006-12-28
CN1739028A (zh) 2006-02-22
AU2003288058A8 (en) 2004-06-03
CA2505923A1 (en) 2004-05-27

Similar Documents

Publication Publication Date Title
DE60128458D1 (de) Anorganische teilchenkonjugate
CY1109554T1 (el) Μεθοδοι και αντιδραστηρια για την ανιχνευση ενδοτοξινης
SE0003285D0 (sv) Kodare
ATE464374T1 (de) Assay zum schnellen nachweis vom humanen aktivierten protein c und hochspezifischer monoklonaler antikörper dagegen
AU2002230842A1 (en) Optical methods and systems for tissue analysis
TR200001765T2 (tr) Duyguları ayırt etmek için aletler ve yöntemler.
AU150306S (en) Specimen processing instrument
NO20031473L (no) Prosessering av hydrokarbon gass
TR199801255T2 (xx) Vitronektin resept�r antagonistleri.
DK0939897T3 (da) Kemisk føler
ATE423216T1 (de) Neue fructosylpeptidoxidase und deren nutzung
MA30922B1 (fr) Anticorps d'agonistes de trkb et leurs utilisations
DE69901569D1 (de) Humane antikörper gegen faktor ix/ixa
EP1395275A4 (en) BETA SECRETASE SUBSTRATES AND THEIR USE
ATE198945T1 (de) Vorrichtung und verfahren zur bestimmung der steifigkeit von blattgut, wie z.b. banknoten
BR9913084A (pt) Agente antitrombótico e anticorpo monoclonal com fator antivon willebrand humanizado
DE60231607D1 (de) Zusammensetzungen und verfahren zum nachweis von ehrlichia canis- und ehrlichia chaffeensis-antikörpern
BR0014626A (pt) Análise de leptina
DE50214765D1 (de) Verfahren und vorrichtung zur auswahl eines klangalgorithmus
ATE313781T1 (de) Mehrschichtiger sensor
BR0314139A (pt) Derivados de 1,4-pirazina substituìdos
ATE238597T1 (de) Akustische vorrichtung
DE60217079D1 (de) Nachweis und quantifizierung von cripto-1
BRPI0411145A (pt) combinações antiartrìticas
DE69132144D1 (de) Menschliche phospholipase aktivierender proteinteil

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.